Anne Elizabeth Clatworthy, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zebrafish | 7 | 2022 | 2997 | 0.690 |
Why?
|
| Virulence | 6 | 2020 | 1298 | 0.570 |
Why?
|
| Anti-Infective Agents | 2 | 2018 | 981 | 0.530 |
Why?
|
| Pseudomonas aeruginosa | 5 | 2022 | 1276 | 0.500 |
Why?
|
| VDJ Recombinases | 2 | 2005 | 84 | 0.470 |
Why?
|
| Embryo, Nonmammalian | 3 | 2018 | 900 | 0.390 |
Why?
|
| Bacterial Infections | 3 | 2018 | 1403 | 0.370 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2018 | 1055 | 0.360 |
Why?
|
| Host-Pathogen Interactions | 4 | 2018 | 1447 | 0.330 |
Why?
|
| Genes, Essential | 3 | 2022 | 184 | 0.270 |
Why?
|
| Virulence Factors | 3 | 2012 | 511 | 0.260 |
Why?
|
| Pseudomonas Infections | 2 | 2011 | 623 | 0.250 |
Why?
|
| Endodeoxyribonucleases | 1 | 2005 | 164 | 0.230 |
Why?
|
| Exodeoxyribonucleases | 1 | 2005 | 195 | 0.220 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2024 | 1903 | 0.220 |
Why?
|
| Genome, Bacterial | 4 | 2022 | 770 | 0.190 |
Why?
|
| beta-Lactam Resistance | 1 | 2020 | 74 | 0.170 |
Why?
|
| Adaptation, Biological | 1 | 2020 | 147 | 0.160 |
Why?
|
| Receptors, Lipoprotein | 1 | 1999 | 88 | 0.160 |
Why?
|
| DNA Repair | 2 | 2005 | 2039 | 0.160 |
Why?
|
| Klebsiella pneumoniae | 1 | 2020 | 255 | 0.150 |
Why?
|
| Tryptophan Synthase | 1 | 2017 | 9 | 0.150 |
Why?
|
| Bacterial Toxins | 2 | 2013 | 931 | 0.150 |
Why?
|
| Chimera | 1 | 2018 | 453 | 0.140 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2012 | 1130 | 0.140 |
Why?
|
| Quorum Sensing | 2 | 2009 | 137 | 0.140 |
Why?
|
| Immune System | 1 | 2022 | 798 | 0.140 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 9585 | 0.140 |
Why?
|
| Azetidines | 1 | 2017 | 141 | 0.130 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2005 | 2698 | 0.130 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 1854 | 0.130 |
Why?
|
| Semicarbazones | 1 | 2013 | 4 | 0.120 |
Why?
|
| Endosomes | 2 | 2013 | 519 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 2414 | 0.110 |
Why?
|
| Bacteria | 2 | 2018 | 2199 | 0.110 |
Why?
|
| Small Molecule Libraries | 2 | 2017 | 734 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 1999 | 1091 | 0.110 |
Why?
|
| Chaperonin Containing TCP-1 | 1 | 2013 | 8 | 0.110 |
Why?
|
| Bacterial Proteins | 3 | 2013 | 3826 | 0.110 |
Why?
|
| Mycolic Acids | 1 | 2013 | 54 | 0.110 |
Why?
|
| Coumarins | 1 | 2013 | 119 | 0.110 |
Why?
|
| Bacillus anthracis | 1 | 2013 | 122 | 0.100 |
Why?
|
| Embryo, Mammalian | 1 | 2018 | 1674 | 0.100 |
Why?
|
| Evolution, Molecular | 1 | 2020 | 1885 | 0.100 |
Why?
|
| Receptors, Immunologic | 1 | 1997 | 1411 | 0.090 |
Why?
|
| Homeostasis | 1 | 2022 | 3306 | 0.090 |
Why?
|
| Polymorphism, Genetic | 3 | 1999 | 4291 | 0.090 |
Why?
|
| Genes, Bacterial | 2 | 2022 | 1071 | 0.090 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2012 | 412 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 18137 | 0.090 |
Why?
|
| Phosphotransferases | 1 | 2011 | 303 | 0.090 |
Why?
|
| Cytosol | 1 | 2013 | 887 | 0.090 |
Why?
|
| Virus Internalization | 1 | 2013 | 494 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2018 | 2050 | 0.080 |
Why?
|
| Drosophila melanogaster | 1 | 2018 | 1710 | 0.080 |
Why?
|
| Caenorhabditis elegans | 1 | 2018 | 1444 | 0.080 |
Why?
|
| Antitubercular Agents | 1 | 2017 | 1373 | 0.080 |
Why?
|
| Plasmids | 2 | 2024 | 2275 | 0.080 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 944 | 0.070 |
Why?
|
| Animals | 11 | 2022 | 167963 | 0.070 |
Why?
|
| Antigens, Bacterial | 1 | 2013 | 1155 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 2 | 2024 | 7408 | 0.070 |
Why?
|
| DNA Transposable Elements | 2 | 2022 | 756 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 1173 | 0.070 |
Why?
|
| Bacterial Adhesion | 1 | 2007 | 306 | 0.070 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2005 | 30 | 0.060 |
Why?
|
| Brain | 3 | 2022 | 26951 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2005 | 6068 | 0.060 |
Why?
|
| Alzheimer Disease | 4 | 1999 | 8547 | 0.060 |
Why?
|
| Genes, Immunoglobulin | 1 | 2005 | 285 | 0.060 |
Why?
|
| DNA-Cytosine Methylases | 1 | 2003 | 17 | 0.060 |
Why?
|
| Genome, Fungal | 1 | 2003 | 203 | 0.050 |
Why?
|
| Apolipoproteins E | 2 | 1998 | 1436 | 0.050 |
Why?
|
| Drug Delivery Systems | 2 | 2017 | 2221 | 0.050 |
Why?
|
| Lipase | 1 | 2024 | 324 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2005 | 1234 | 0.050 |
Why?
|
| Mice | 5 | 2020 | 81208 | 0.040 |
Why?
|
| Carbon | 1 | 2024 | 669 | 0.040 |
Why?
|
| Phenotype | 1 | 2018 | 16546 | 0.040 |
Why?
|
| Blastula | 1 | 2018 | 15 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 2003 | 911 | 0.040 |
Why?
|
| Carbapenems | 1 | 2020 | 123 | 0.040 |
Why?
|
| Isomerism | 1 | 1999 | 197 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 2022 | 652 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 4573 | 0.040 |
Why?
|
| Bacterial Capsules | 1 | 2020 | 242 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 1998 | 60 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2020 | 915 | 0.040 |
Why?
|
| Klebsiella Infections | 1 | 2020 | 147 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 1526 | 0.040 |
Why?
|
| Neurofibrillary Tangles | 2 | 1998 | 457 | 0.040 |
Why?
|
| Cell Fusion | 1 | 2018 | 293 | 0.040 |
Why?
|
| Antigens, CD1 | 1 | 2000 | 439 | 0.040 |
Why?
|
| Cell Tracking | 1 | 2018 | 138 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2000 | 801 | 0.030 |
Why?
|
| Larva | 1 | 2018 | 509 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2018 | 562 | 0.030 |
Why?
|
| Introns | 1 | 1999 | 978 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2017 | 426 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2024 | 1804 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2003 | 2668 | 0.030 |
Why?
|
| Cerebral Arteries | 1 | 1998 | 493 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2000 | 1254 | 0.030 |
Why?
|
| Gene Frequency | 2 | 1998 | 3615 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2018 | 820 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2020 | 814 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2003 | 3442 | 0.030 |
Why?
|
| Apolipoprotein E4 | 1 | 1997 | 707 | 0.030 |
Why?
|
| Phylogeny | 1 | 2020 | 2775 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 1982 | 0.030 |
Why?
|
| Genomics | 2 | 2022 | 5794 | 0.020 |
Why?
|
| Humans | 12 | 2024 | 760621 | 0.020 |
Why?
|
| Genotype | 4 | 1999 | 12960 | 0.020 |
Why?
|
| Amyloidosis | 1 | 1998 | 817 | 0.020 |
Why?
|
| beta-Lactamases | 1 | 2013 | 304 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 6216 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 2414 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 2693 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2018 | 2379 | 0.020 |
Why?
|
| Reference Values | 1 | 1997 | 4925 | 0.020 |
Why?
|
| Alleles | 2 | 1998 | 6898 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2018 | 2533 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 3616 | 0.020 |
Why?
|
| Binding Sites | 1 | 2017 | 6048 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9530 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 1964 | 0.020 |
Why?
|
| Models, Biological | 1 | 2003 | 9467 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2013 | 1949 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 1998 | 2660 | 0.020 |
Why?
|
| Cell Movement | 1 | 2018 | 5206 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 5039 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 1999 | 11071 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 2846 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2019 | 5075 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2020 | 18957 | 0.010 |
Why?
|
| Cell Line | 2 | 2013 | 15620 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3775 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1999 | 7850 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 40165 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2012 | 8313 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 15789 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 22023 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 2000 | 242 | 0.010 |
Why?
|
| Glycolipids | 1 | 2000 | 204 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 5785 | 0.010 |
Why?
|
| Isoleucine | 1 | 1998 | 110 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 1999 | 58995 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2000 | 513 | 0.010 |
Why?
|
| Macrophages | 1 | 2013 | 5745 | 0.010 |
Why?
|
| Neurons | 1 | 1997 | 9426 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 1433 | 0.010 |
Why?
|
| Cohort Studies | 2 | 1998 | 41335 | 0.010 |
Why?
|
| Apolipoprotein E2 | 1 | 1998 | 135 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 2000 | 928 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 1693 | 0.010 |
Why?
|
| Clone Cells | 1 | 2000 | 1660 | 0.010 |
Why?
|
| Valine | 1 | 1998 | 409 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1999 | 863 | 0.010 |
Why?
|
| Presenilin-1 | 1 | 1999 | 660 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9411 | 0.010 |
Why?
|
| Female | 4 | 2020 | 391270 | 0.010 |
Why?
|
| Aged | 3 | 1999 | 169152 | 0.010 |
Why?
|
| Middle Aged | 2 | 1998 | 220352 | 0.000 |
Why?
|
| Male | 3 | 2018 | 359744 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1998 | 9716 | 0.000 |
Why?
|
| Adult | 1 | 2020 | 219994 | 0.000 |
Why?
|
| Amyloid beta-Peptides | 1 | 1998 | 3832 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1998 | 12159 | 0.000 |
Why?
|
| DNA | 1 | 1998 | 7233 | 0.000 |
Why?
|
| Logistic Models | 1 | 1998 | 13314 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 9185 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2000 | 10181 | 0.000 |
Why?
|
| Age Factors | 1 | 1998 | 18416 | 0.000 |
Why?
|